newsfilter
← Latest News
GlobeNewswire·

Autolus Therapeutics to Participate in Upcoming Investor Conferences

LONDON, May 29, 2025 (GLOBE NEWSWIRE) -- Autolus Therapeutics plc (NASDAQ:AUTL), an early commercial-stage biopharmaceutical company developing, manufacturing and delivering next-generation programmed T cell therapies,